Literature DB >> 8060645

Echocardiographic diagnosis of mitral valve prolapse.

P M Shah1.   

Abstract

The present editorial, besides providing a historical review, offers a succinct definition and a new classification and terminology. It is hoped that this or a similar classification would clarify some of the confusion surrounding the diagnosis of mitral valve prolapse. The current echocardiographic criteria are reviewed. Some difficulty in the diagnosis of milder forms of prolapse is inevitable because a distinction between normal bulging and excessive hooding may be subtle in such cases. The proposed criteria using multiple echocardiographic cross sections (rather than the long-axis view alone) is more likely to provide a comprehensive visualization of several components of the leaflets and avoid errors of underdiagnosis of localized myxomatous prolapse abnormality. The criteria and discussion are based on the author's experience and interest in the diagnosis of this condition and clinical correlations with intraoperative findings. If the cardiac surgeons and the echocardiologists could agree on a common terminology and classification scheme, it could result in better anatomic correlations of the echocardiographic findings in this condition and potentially result in improved patient care.

Entities:  

Mesh:

Year:  1994        PMID: 8060645     DOI: 10.1016/s0894-7317(14)80399-4

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  2 in total

1.  A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Authors:  Lisa A Freed; James S Acierno; Daisy Dai; Maire Leyne; Jane E Marshall; Francesca Nesta; Robert A Levine; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-04-21       Impact factor: 11.025

Review 2.  Imaging of Mitral Valve Prolapse: What Can We Learn from Imaging about the Mechanism of the Disease?

Authors:  Ronen Durst; Dan Gilon
Journal:  J Cardiovasc Dev Dis       Date:  2015-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.